Pfizer loses key Lyrica patent battle in the UK; Kleo Pharma closes $21M Series B round
→ The UK Supreme Court ruled against Pfizer $PFE and a patent involving its blockbuster painkiller Lyrica, in a major blow to the US …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
